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Abstract
Exon junction complexes (EJCs) link nuclear splicing to key features of mRNA function including mRNA stability, translation,
and localization. We analyzed the formation of EJCs by the spliceosome, the physiological EJC assembly machinery. We
studied a comprehensive set of eIF4A3, MAGOH, and BTZ mutants in complete or C-complex–arrested splicing reactions
and identified essential interactions of EJC proteins during and after EJC assembly. These data establish that EJC deposition
proceeds through a defined intermediate, the pre-EJC, as an ordered, sequential process that is coordinated by splicing. The
pre-EJC consists of eIF4A3 and MAGOH-Y14, is formed before exon ligation, and provides a binding platform for peripheral
EJC components that join after release from the spliceosome and connect the core structure with function. Specifically, we
identified BTZ to bridge the EJC to the nonsense-mediated messenger RNA (mRNA) decay protein UPF1, uncovering a
critical link between mRNP architecture and mRNA stability. Based on this systematic analysis of EJC assembly by the
spliceosome, we propose a model of how a functional EJC is assembled in a strictly sequential and hierarchical fashion,
including nuclear splicing-dependent and cytoplasmic steps.
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Introduction
Gene expression in eukaryotes involves multiple post-transcrip-
tional steps, including pre–messenger RNA (mRNA) processing,
the export of the mature mRNA to the cytoplasm, its correct
intracellular localization, and finally its translation and turnover
[1,2]. All these processes are coordinated by a network of
communicating cellular machines [3]. The exon junction complex
(EJC) plays a central role in the coordination of post-transcrip-
tional gene expression in metazoan cells. The EJC is deposited on
nascent mRNAs during splicing in a sequence-independent
manner 20–24 nucleotides (nts) upstream of exon–exon junctions
[4]. EJCs communicate the pre-splicing architecture of a spliced
mRNA to cytoplasmic processes and modulate central events in
gene expression such as nuclear mRNA export, mRNA quality
control by nonsense-mediated mRNA decay (NMD), and
translation of mRNAs in the cytoplasm [5–7].
NMD represents an intensively studied splicing- and translation-
dependent process that limits the expression of abnormal
transcripts containing premature termination codons and controls
the expression of normal mRNA isoforms that are generated from
the same pre-mRNA at different times of development and in
different tissues [8–11]. As such, NMD has broad biological and
medical implications [12]. NMD can be recapitulated by
introducing a functional intron into the 39 untranslated region
(UTR) of an otherwise wild-type mRNA or by tethering either of
the EJC components MAGOH, Y14, eIF4A3 (DDX48), or
Barentsz (BTZ, also referred to as MLN51 or CASC3) to the 39
UTR of reporter mRNAs in human cells [13–17]. These data
indicate that the presence of an EJC at an appropriate distance
downstream of a termination codon is sufficient to elicit NMD and
suggest that the EJC provides the direct molecular link for the
recognition of premature translation termination codons.
The core of the EJC, consisting of the four proteins eIF4A3,
MAGOH, Y14, and BTZ, can be assembled from recombinant
subunits in vitro when its components are simultaneously present
[18]. Such in vitro assembly of the EJC core also requires the
presence of ATP and single-stranded RNA, both of which are an
integral part of the complex [18]. The crystal structure of this core
EJC bound to oligo-U RNA shows that eIF4A3 binds the
phosphate–sugar backbone of the RNA via its DEAD-box helicase
domain. This structure explains why the binding of RNA by the
EJC is stable and specific for RNA, despite being sequence-
independent [19,20]. Binding of RNA requires simultaneous
binding of a molecule of ATP, whereas ATP hydrolysis by
eIF4A3’s inherent ATPase activity leads to the dissociation of the
EJC from the RNA [18]. To stably clamp the EJC on the RNA,
the ATPase activity of eIF4A3 is inhibited by the binding of the
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can undergo a remarkable structural reorganization [19,20].
Whereas BTZ binds eIF4A3 in both the open and the closed
RNA-bound conformations, MAGOH-Y14 binding to eIF4A3
occurs only in its RNA-bound state.
The protein PYM also plays an important role both in the
function and in the recycling of EJCs. Ribosome-associated PYM
binds to the EJC components MAGOH-Y14 [21], thereby
recruiting ribosomes to spliced mRNAs to stimulate translation
as well as directing the disassembly of EJCs in the cytoplasm
[22,23].
The determination of the crystal structure of the biochemically
assembled EJC core has been a milestone in the analysis of EJC
function. However, a better biological understanding of EJC
assembly will have to integrate this structural information with the
fact that EJC assembly in vivo is strictly splicing-dependent
[4,24,25]. We have thus investigated spliceosome-dependent EJC
assembly and demonstrate that the EJC is assembled along a
defined hierarchical pathway that ensures the proper positioning
and stable binding of the EJC on the (pre-)mRNA substrate. Our
data define a stable minimal pre-EJC core consisting of eIF4A3
and MAGOH-Y14, which serves as a binding platform for EJC
binding factors like BTZ and UPF3b that link the EJC to
functional downstream effectors.
Results
Splicing-Dependent EJC Assembly In Vitro
We first established an experimental system to investigate the
splicing-dependent deposition of EJC components with MINX pre-
mRNA that contains an intron that activates NMD when
introduced into the 39 UTR of a b-globin mRNA [17]. HeLa
nuclear extract was supplemented with splicing-competent whole-
cell extracts from HEK293 cells expressing different FLAG-tagged
EJC proteins (Figure 1B). When MINX transcripts are incubated
under splicing conditions in such mixed HeLa-HEK293 extracts,
they are spliced efficiently and processed to mRNAs of the expected
size (Figure 1A). From these splicing reactions, the FLAG-tagged
EJC proteins are immunoprecipitated together with their associated
mRNAs. As expected for EJC proteins, the fully spliced mRNAs
specifically co-immunoprecipitate with FLAG-eIF4A3, -BTZ, -
MAGOH, -Y14, and -UPF3b. In contrast, only small amounts of
splicing intermediates or pre-mRNAs associate with FLAG-eIF4A3,
-MAGOH, -Y14, or BTZ (Figure 1A). These immunoprecipitations
are specific for spliced RNAs, as only traces of an intronless MINX
transcript (MINX Di) are pulled down under the same conditions
(Figure 1C). As expected, the intronless transcript co-immunopre-
cipitates with FLAG-CBP80 (Figure 1D). This protein associates
with mRNAs in a splicing-independent but cap-dependent manner,
and hence serves as a positive control for the overall integrity and
protein binding capacity of the MINX Di RNA.
eIF4A3 and MAGOH-Y14 Form a Pre-EJC before Exon
Ligation
Purified spliceosomes, as well as purified spliceosomal C-
complexes, contain the EJC proteins eIF4A3, Y14, and MAGOH
[26–28]. This poses the question of when and in which order
individual EJC proteins are recruited to the RNA during splicing.
To answer this question, we performed FLAG immunoprecipita-
tions from splicing reactions using a MINX pre-mRNA with a GG
mutation of the 39 splice site. This manipulation completely blocks
splicing after intron lariat formation and before exon ligation, and
also noticeably decreases the efficiency of the first step of splicing
[29,30]. The splicing intermediates (intron lariat-39 exon, 59 exon)
and pre-mRNA are specifically precipitated via eIF4A3, MA-
GOH, and Y14 (Figure 1E, lanes 8, 10, and 11). Whereas UPF3b
precipitates the pre-mRNA only marginally above background
and fails to precipitate splicing intermediates, BTZ precipitates
some pre-mRNA and also no intermediates (Figure 1E, lanes 9
and 12). BTZ may thus interact with the pre-mRNA under these
conditions, but is not detectable in the lariat mRNP. This finding
implies that BTZ and UPF3b appear not to associate with the
RNA at an early step of splicing, but are rather recruited at later
stages or after splicing of the mRNA has been completed. This
result was expected for UPF3b and confirms the current view that
UPF3b binds only to the fully assembled EJC after release of the
spliceosome. In contrast, we were surprised to discover that BTZ
does not associate with eIF4A3 during splicing and may even be
actively excluded from the spliceosomal C-complex (see below),
because BTZ can interact with eIF4A3 in vitro even in the absence
of Y14 and MAGOH [20,31].
These results show that the biochemically defined EJC core is
assembled by the spliceosome in a stepwise manner. The three
proteins eIF4A3, MAGOH, and Y14 first assemble on the RNA to
form a pre-EJC, which is subsequently bound by BTZ (and
UPF3b) to yield the core EJC. This assembly hierarchy predicts
either that BTZ binds to eIF4A3 during the second step of splicing
(after the minimal trimeric pre-EJC is fully assembled), or that
binding occurs when the spliceosome has dissociated from the
mRNA. To distinguish between these two alternatives, splicing
reactions were performed in extracts with or without the initial
addition of HEK293 cell extracts expressing the FLAG-tagged
EJC proteins (Figure 1F). Reactions that initially lacked FLAG-
tagged proteins were supplemented with the same amount of
FLAG-extracts after the completion of splicing and chased on ice
to monitor the exchange of EJC-bound factors with supplemented
proteins. Afterwards, recombinant proteins and associated
mRNAs were affinity selected by FLAG immunoprecipitation.
The EJC proteins eIF4A3, MAGOH, and Y14 co-purified with
spliced mRNA only if they were present before the beginning of
splicing (Figure 1F, lanes 13, 14, 17–20). This result is expected for
Author Summary
The first step in the expression of eukaryotic protein-coding
genes is transcription into a messenger RNA (mRNA)
precursor in the nucleus. These precursor mRNAs then
undergo maturation through the removal of introns in a
process termed splicing. During splicing, the splicing
machinery or ‘‘spliceosome’’ deposits a complex of proteins
onto the mRNA that accompanies it during post-transcrip-
tional steps in gene expression, including the regulation of
mRNA stability, transport out of the nucleus, cellular
localisation, and translation. This complex, the exon
junction complex (EJC), represents a molecular memory of
the splicing process. Understanding the biogenesis of EJCs
and their downstream effects helps reveal the basic
principles by which the primary steps of mRNA synthesis
are coupled to the regulation of gene expression. Here we
show that EJCs are assembled in a strictly splicing-
dependent manner through an unexpected, coordinated,
and hierarchical assembly pathway. Importantly, we show
that the EJC recruits the cytoplasmic protein BTZ, which
then bridges the complex to an mRNA quality-control
machinery called the nonsense-mediated decay pathway
that degrades mRNAs containing premature stop codons.
This finding suggests that the EJC and bridging by BTZ help
determine the stability of mRNA and thus are essential for
proper cellular surveillance of mRNA quality.
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PLoS Biology | www.plosbiology.org 2 May 2009 | Volume 7 | Issue 5 | e1000120Figure 1. Ordered, spliceosome-mediated assembly of the EJC. (A) Splicing reactions using MINX as substrate RNA were supplemented with
extracts expressing the indicated FLAG-tagged EJC proteins or unfused FLAG-tag as negative control. Reactions were immunoprecipitated with FLAG
affinity gel. Positions of the unspliced transcript and the spliced product are displayed schematically. Twelve percent of the total input material was
loaded in the input panel. (B) Expression of the FLAG-proteins used in (A) determined by immunoblot analysis with a FLAG antibody. (C) Splicing
reactions and immunoprecipitations were performed as in (A) with an intronless MINX transcript (MINX Di). (D) Splicing reactions and
immunoprecipitations with FLAG-CBP80 or unfused FLAG employing the intronless MINX transcript (MINX Di) used in (C). (E) Splicing reactions and
immunoprecipitations were performed as in (A) with a mutated MINX transcript (MINX GG) that does not undergo exon ligation. Positions of the
unspliced transcript and the splicing intermediates (exon 1; lariat and exon 2) are displayed schematically. 8% of the total input material was loaded
in the input panel. (F) Splicing reactions were performed in the presence (lanes 2, 4, 6, 8, 10, 13, 15, 17, 19, and 21) or absence (lanes 3, 5, 7, 9, 11, 14,
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with little exchange of components after EJC assembly and the
completion of splicing. Interestingly, BTZ and UPF3b co-purify
with the spliced mRNA independent of whether they were added
before or after splicing (Figure 1F). Thus, BTZ and UPF3b bind to
the minimal trimeric pre-EJC that is loaded onto the RNA in a
splicing-dependent manner, but themselves do not require splicing
for EJC binding. Similar results were obtained when splicing
reactions were supplemented with recombinant proteins instead of
HEK293 cell extracts (Figure S1).
MAGOH-Y14 Requires eIF4A3 for EJC Binding
We next defined the functions of the individual EJC proteins
during the assembly of the EJC as well as their roles in NMD.
Considering the published crystal structures of the MAGOH-Y14
heterodimer [13,32,33], the MAGOH-Y14-PYM trimer [21], and
the EJC [19,20], we used mutants of MAGOH, eIF4A3, and BTZ
that were designed to specifically disrupt important interaction sites.
FLAG immunoprecipitation experiments were performed to
characterize protein–protein interactions of the MAGOH mutants
(Figure 2A and Table S1). In agreement with previous data [14]
and their position within the EJC, each mutant belongs to one of
three different classes: (1) mutants that do not bind PYM (68, 72/
73, 117; Figure 2B, lanes 3–5), (2) mutants that bind neither PYM
nor UPF3b (66/68; Figure 2B, lane 6), or (3) mutants that do not
bind eIF4A3, BTZ, and UPF3b (16/17, 20, 39/40, 41/42, 130/
134; Figure 2B, lanes 7–11). For previously described MAGOH
mutants, comparable co-immunoprecipitation results were ob-
tained with endogenous Y14, PYM, eIF4A3, UPF3b, and BTZ
[14], indicating that the tagged proteins reflect the function of the
endogenous proteins. We next analyzed the function of the
different mutants in NMD by using a tethering system. The
activation of NMD in this assay is achieved by single EJC proteins
tethered to the 39 UTR of a reporter mRNA. This experimental
system has served in functional analyses of mutant NMD factors
and to dissect different steps of the NMD pathway(s)
[14,15,34,35]. These useful properties of tethering experiments
must, however, be seen against the background that the
physiological situation is not likely reflected in full because of the
inherently artificial nature of the assay and the fact that some of
the steps of EJC assembly are bypassed. In NMD tethering assays,
mutants of the three groups display distinct characteristics
(Figure 2C). Class 1 mutants are as active as the wild-type
MAGOH (lanes 3–5), while the class 2 mutant is approximately 2-
fold less active (lane 6), consistent with previously reported data
[14]. Strikingly, the class 3 mutants are inactive or show a
dramatically reduced NMD activity (Figure 2C, lanes 7–11).
Taken together, these results suggest that tight binding of UPF3b
to MAGOH is not strictly required for NMD in the context of
tethered MAGOH. This finding is consistent with a report of a
UPF3-independent NMD pathway [36] and the normal NMD
efficiency of UPF3b-deficient cells [37]. By contrast, the
recruitment of eIF4A3 and BTZ appears to be a prerequisite for
efficient activation of NMD in the context of tethered MAGOH
(Figure 2C, lanes 7–11).
We selected six representative MAGOH mutants from the three
different classes to analyze their association with the completely
spliced mRNA (Figure 2D) and with the trapped intron-lariat
(Figure 2E). The different classes of mutants display distinct
differences regarding EJC formation compared to wild-type
MAGOH. Class 1 mutants co-immunoprecipitate slightly, but
reproducibly more spliced MINX mRNA (Figure 2D, compare
lanes 11 and 12 with lane 10). The class 2 mutant precipitates
similar amounts of MINX RNA as wild-type MAGOH (compare
lanes 10 and 13). Finally, class 3 mutants fail to associate with the
spliced MINX mRNA. These results fit well with earlier data that
implicate eIF4A3 as the RNA-binding platform for the other EJC
proteins and that suggested that both MAGOH and Y14 associate
with RNA indirectly by binding to eIF4A3 [13,18–20,38].
Additionally, these data indicate that the interaction of PYM with
MAGOH-Y14 is not required for the stable assembly of the EJC.
Our analyses of the lariat RNP (C-complex) with class 1 and class
2 mutants of MAGOH (Figure 2E) demonstrate that neither PYM
nor UPF3b are required for loading of MAGOH onto the pre-
mRNA and for the interaction of MAGOH with the C-complex
(lanes 10–13). In contrast, the class 3 mutants show that MAGOH
requires its eIF4A3 interaction to efficiently associate with the pre-
mRNA and with the splicing intermediates of the C-complex
(Figure 2E, lanes 14–16). These data suggest that MAGOH and
Y14 are recruited to the RNA via their eIF4A3 interaction. This
recruitment step of MAGOH-Y14 may be mediated exclusively by
eIF4A3, but it could involve additional interactions of MAGOH-
Y14 with spliceosomal proteins.
eIF4A3 Is Loaded onto the mRNA by Splicing and
Requires MAGOH-Y14 for Tight RNA Binding
Next, mutants of eIF4A3 (Figure 3A) were generated that lack
binding to either MAGOH-Y14 (223, 401/402; class 1) or BTZ
(154/155, 178/179, 205/206, 232; class 2). In addition, point
mutations within the ATP binding pocket of eIF4A3 were
generated that are expected to interfere with ATP binding
(labeled ATP in Figure 3A). FLAG immunoprecipiations were
performed to analyze the interaction of these mutants with BTZ,
UPF3b, Y14, and MAGOH(Figure 3B). As expected, the class 1
mutants 223 and 401/402 fail to co-precipitate MAGOH-Y14
(Figure 3B, lanes 3 and 4). Similarly, only traces of UPF3b are
detectable. The interaction with BTZ is not affected by the 401/
402 mutation, whereas the 223 mutation decreases this interaction
slightly. By contrast, the class 2 mutants 154/155, 178/179, 205/
206, and 232 abolish the interaction of eIF4A3 with BTZ, while
the MAGOH-Y14 interaction is maintained, albeit at a reduced
level (lanes 5–8). Co-precipitation of UPF3b is also detected, albeit
less than with wild-type eIF4A3 (lane 2), but considerably more
than seen with the class 1 mutants. All three ATP binding mutants
fail to co-precipitate MAGOH-Y14 and bind only traces of
UPF3b (lanes 9–11), one mutant does not precipitate BTZ (lane 9).
The two other mutants, however, co-precipitate significant
amounts of BTZ (lanes 10 and 11). Hence, the binding of eIF4A3
to BTZ or MAGOH-Y14 can be separated and thus occur
independently from one another. These results also indicate that
UPF3b binding to the EJC requires a heterotrimer consisting of
eIF4A3, MAGOH, and Y14 and is likely supported by BTZ.
Binding of MAGOH-Y14 occurs apparently only in the ATP-
bound closed conformation, whereas BTZ binding occurs
independently of ATP binding.
We next tested the class 1 and the class 2 eIF4A3 mutants in the
NMD tethering assay. Surprisingly, MAGOH-Y14 binding (and
hence tight UPF3b binding) is not required for NMD activity of
16, 18, 20, and 22) of FLAG-protein extracts or with unfused FLAG as negative control (lanes 1 and 12). Reactions without added FLAG-proteins were
supplemented after the completion of splicing with FLAG-protein extracts and incubated on ice (30 min). Immunoprecipitations were done as in (A),
except that 15% of the total input material was loaded in the input panel.
doi:10.1371/journal.pbio.1000120.g001
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eIF4A3 shows markedly reduced or no NMD activity when BTZ
binding is abolished (Figure 3C, lanes 5–8). This finding nicely
complements earlier data, which demonstrated that siRNA-
mediated depletion of BTZ abrogates NMD elicited by tethered
eIF4A3 [14]. Thus, in the context of tethered eIF4A3, the tight
binding of MAGOH-Y14 is dispensable (although the faintly
detectable binding of UPF3b may rescue some of the eIF4A3
function), but BTZ is required for NMD. It may appear from these
data that a loss of the eIF4A3-BTZ pathway (Figure 3C, lanes 5–-)
may have a stronger functional effect than the loss of the eIF4A3-
UPF3b pathway (Figure 3C, lanes 3 and 4). However, because of
the limitations of the tethering assay, the relevance of quantitative
differences for NMD pathways remains to be explored in more
depth.
We also used the complete set of mutant eIF4A3 proteins to
analyze their ability to serve as EJC assembly platforms, both after
completed splicing and at the step of C-complex formation
(Figure 3D and 3E). Remarkably, eIF4A3 tolerates the lack of
BTZ but not of MAGOH-Y14 or ATP binding to co-
immunoprecipitate significant amounts of spliced mRNA
(Figure 3D). Thus, the assembly of a stable (pre-)EJC does not
Figure 2. MAGOH-Y14 are recruited to the EJC by eIF4A3. (A) Scheme of the positions of the MAGOH mutants in the EJC. The interactions
with UPF3b and PYM are indicated by arrows. BTZ residues present in the crystal structure are displayed in red, an arbitrary shape of full length BTZ is
suggested in light red. The EJC structure was rendered using PyMOL [54] with structural data deposited in the Protein Data Bank (http://www.rcsb.
org/pdb/home/home.do; ID: 2j0s). (B) Immunoprecipitations were done from RNAse A-treated lysates of HeLa cells that were transfected with FLAG-
MAGOH and FLAG-MAGOH mutants or unfused FLAG as negative control together with V5-tagged BTZ, UPF3b, eIF4A3, PYM, and Y14. Co-
precipitated proteins were detected by immunoblotting using an anti V5 antibody. (C) Northern blot analysis of RNA from HeLa cells that were
transfected with expression plasmids for lNV5-tagged MAGOH or mutants of MAGOH together with the 4boxB reporter plasmid and the transfection
control plasmid. Percentages (%) represent the mean of four independent experiments6standard deviations (SD). Bottom panel: expression levels of
the tethered MAGOH mutant proteins were detected by immunoblot analysis with a V5-specific antibody. GFP served as internal loading control. (D)
Splicing reactions using MINX as substrate RNA were supplemented with extracts expressing the indicated FLAG-tagged MAGOH mutants or unfused
FLAG-tag as negative control. Reactions were immunoprecipitated with FLAG affinity gel. Twelve percent of the total input material was loaded in the
input panel. (E) Splicing reactions and immunoprecipitations were performed as in (D) with the mutated MINX GG transcript.
doi:10.1371/journal.pbio.1000120.g002
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indispensable, likely because they inhibit the ATPase activity of
eIF4A3 and thus stabilize the complex [18]. The lack of ATP
binding likely interferes with conformational changes as well as
binding to MAGOH-Y14, explaining why these mutants fail to
precipitate mRNA. When splicing is arrested before exon ligation,
all eIF4A3 mutants immunoprecipitate less splicing intermediates
than wild-type eIF4A3 does. When BTZ binding is abolished
(lanes 5–8), three of the eIF4A3 mutants still co-precipitate
significant amounts of RNA. To estimate the incorporation of the
different mutants into either the spliceosomal C-complex (MINX
GG) or the mature EJC (MINX), we compared the relative
amounts of precipitated MINX and MINX GG for all eIF4A3
mutants. Interestingly, the class 1 mutants and the ATP binding
mutants specifically impaired the stability of the EJC after the
completion of splicing (up to 12-fold less relative MINX
precipitation for class 1 mutants and up to 22-fold less for ATP
binding mutants; Figure 3F), while the class 2 mutants do not
affect the mature EJC (Figure 3F). Taken together, these data
show that neither MAGOH-Y14 nor BTZ are completely
Figure 3. Functional analysis of eIF4A3 in EJC assembly and NMD. (A) Positions of the eIF4A3 mutants within the EJC as shown in Figure 2.
Mutants in the ATP binding pocket on the inside of the protein and are not shown. (B) Immunoprecipitations were done from RNAse A-treated
lysates of HeLa cells, which were transfected with FLAG-eIF4A3 and FLAG-eIF4A3 mutants or unfused FLAG as negative control together with V5-
tagged BTZ, UPF3b, Y14, and MAGOH. Co-precipitated proteins were detected by immunoblotting using an anti V5 antibody. (C) Northern blot
analysis of total cytoplasmic RNA from HeLa cells that were transfected with expression plasmids for MS2-tagged eIF4A3 or mutants of eIF4A3
together with the 6MS2 reporter plasmid and the transfection control plasmid. Percentages (%) represent the mean of 3 independent
experiments6standard deviations (SD). Bottom panel: expression levels of the tethered eIF4A3 mutants were detected by immunoblot analysis with
a MS2-specific antibody. GFP served as internal loading control. (D) Splicing reactions using MINX as substrate RNA were supplemented with extracts
expressing the indicated FLAG-tagged eIF4A3 mutants or unfused FLAG-tag as negative control. Reactions were immunoprecipitated with FLAG
affinity gel. Twelve percent of the total input material was loaded in the input panel. (E) Splicing reactions and immunoprecipitations were performed
as in (C) with the mutated MINX GG transcript. (F) The amounts of MINX or MINX GG RNA immunoprecipitated by eIF4A3 mutants as shown in (C) and
(D) were normalized to the amount precipitated by the eIF4A3 wild-type. Mutants that precipitated a lower relative amount of MINX compared to
MINX GG were considered to destabilize the EJC during or after completion of splicing (red columns). Conversely, mutants that precipitated higher
amounts of MINX compared to MINX GG were considered to increase the stability of the mature EJC (green columns).
doi:10.1371/journal.pbio.1000120.g003
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and that MAGOH-Y14 and ATP (but not BTZ) are needed to
stabilize the pre-EJC after splicing has been completed. Further-
more, MAGOH-Y14 are not required for NMD if eIF4A3 is
stably associated with the RNA by tethering. Finally, the binding
of BTZ to eIF4A3 is required for NMD, suggesting that this
interaction helps establish a link to downstream NMD factors.
Positioning of eIF4A3 during Splicing
The data described above indicate that an ordered assembly
hierarchy ensures the proper loading of EJCs during splicing and
the function of EJCs in downstream processes such as NMD. Since
EJC assembly from recombinant subunits on RNAs is not
position-specific, whereas the spliceosome-mediated process is,
we next aimed to identify the steps involved in EJC positioning by
the spliceosome. To this end, we generated two additional MINX
transcripts with shortened 59 exons (15 nts), based on the
constructs shown in Figure 1A and 1D with either the wild-type
(AG) or the mutant GG 39 splice site (MINX (15) and MINX GG
(15); Figure 4D). Since the EJC is deposited onto the mRNA 20–
24 nts upstream of the splice junction [4,39,40], our transcripts
with the shortened 59 exons lack physiologically defined EJC
binding sites. We performed FLAG immunoprecipitations with all
four transcripts after in vitro splicing with FLAG-tagged eIF4A3
and Y14. As shown before, eIF4A3 and Y14 precipitate the spliced
MINX mRNA (Figure 4A, lanes 4–6). In contrast, spliced MINX
(15) mRNA is not co-immunoprecipitated by either eIF4A3 or
Y14, which confirms that this transcript lacks an EJC binding site
(Figure 4A, lanes 10–12). The MINX GG transcript that does not
undergo the second step of splicing is also co-immunoprecipitated
with both proteins (Figure 4B, lanes 4–6), whereas, interestingly,
the MINX GG (15) transcript, lacking an EJC binding site is co-
precipitated with eIF4A3, but not Y14 (Figure 4B, compare lanes
11 and 12). eIF4A3 thus associates with early intermediates of the
splicing reaction even when the RNA lacks an EJC binding site,
but the association of eIF4A3 with the RNA is completely lost after
the completion of splicing (Figure 4A, lane 11, see fully spliced
product). This finding can be explained by two alternative models:
(a) at an early step of EJC assembly, eIF4A3 binds to the RNA at a
different position that is contained in MINX (15) and shifts later to
the correct position; or (b) early binding of eIF4A3 to the RNA is
indirect and mediated by additional factors, such as components of
the spliceosome.
In order to distinguish between these models, we performed
splicing reactions with the three transcripts that co-immunopre-
cipitate with eIF4A3 (MINX, MINX GG, and MINX GG (15)).
After the completion of splicing, the samples were subjected to
FLAG immunoprecipitation in the presence of the detergent
Empigen BB (Figure 4C), which dissociates all but strong protein–
protein and protein–RNA interactions. Under these conditions,
eIF4A3 and Y14 co-immunoprecipitate only MINX and MINX
GG RNAs that contain an EJC binding site (Figure 4C, lanes 5, 6,
11, and 12). In contrast, MINX GG (15) RNA is no longer co-
immunoprecipitated by eIF4A3 under these stringent conditions
(lane 17). Comparable results were obtained when the samples
were UV-crosslinked before immunoprecipitation (Figures S2 and
S3). This result demonstrates that the association of eIF4A3 with
the MINX GG (15) RNA is mediated by interactions that are
Figure 4. Successive formation of a trimeric pre-EJC. (A) Splicing reactions using MINX or MINX (15) as substrate RNAs were supplemented
with FLAG-eIF4A3, FLAG-Y14, or FLAG-expressing extracts. Immunoprecipitations were done with FLAG affinity gel. Lanes with transcripts are labeled
T. Twelve percent of the total input material was loaded in the input lanes. (B) Splicing reactions using MINX GG or MINX GG (15) as substrate RNAs
were supplemented with FLAG-eIF4A3, FLAG-Y14, or FLAG-expressing extracts. Immunoprecipitations were done with FLAG affinity gel. Twelve
percent of the total input material was loaded in the input lanes. (C) Splicing reactions using MINX, MINX GG, or MINX GG (15) as substrate RNAs were
supplemented with FLAG-eIF4A3, FLAG-Y14, or FLAG-expressing extracts. Immunoprecipitations were done with FLAG affinity gel in the presence of
1% Empigen BB. Twelve percent of the total input material was loaded in the input lanes. (D) Schematic representation of the transcripts used in (A–
C). Exons and introns are displayed as boxes and lines, respectively.
doi:10.1371/journal.pbio.1000120.g004
Assembly of the Exon Junction Complex
PLoS Biology | www.plosbiology.org 7 May 2009 | Volume 7 | Issue 5 | e1000120weaker than those within the fully assembled EJC. It also shows
that Empigen BB-resistant EJCs can be detected within the C-
complex, if an RNA binding site for the EJC is present. Y14 does
not detectably associate with the MINX GG (15) RNA, even in the
absence of a strong detergent (Figure 4B, lane 12). We suggest that
MAGOH-Y14 binding may require a conformation of eIF4A3
,which depends on its binding to the RNA EJC site. Taken
together, these results indicate that during early phases of splicing,
eIF4A3 interacts with the RNA indirectly, likely via spliceosomal
proteins. Afterwards and possibly during one of the remodeling
steps involved in spliceosome activation, eIF4A3 is directly
deposited onto the RNA, which likely induces a conformational
change that allows eIF4A3 to bind MAGOH-Y14, which may
already be associated with the spliceosome.
BTZ Associates with the EJC via eIF4A3
Among the EJC core components, BTZ has unique character-
istics: (1) it binds to the EJC after the completion of splicing
(Figure 1), and (2) it is mostly cytoplasmic at steady state [41,42].
Hence, BTZ may join the exported mRNP in the cytoplasm. We
analyzed the features of BTZ that are required for its function
during EJC biogenesis and NMD. Considering the crystal
structure, we generated BTZ mutations to disrupt the binding of
BTZ to eIF4A3 (Figure 5A). FLAG immunoprecipitation analysis
of our BTZ mutants confirmed that their interaction with eIF4A3
(and indirectly with MAGOH-Y14) is indeed diminished albeit to
different degrees (Figure 5B). Particularly the 218 mutant is
severely impaired in its interaction with eIF4A3 (Figure 5B,
compare lane 6 with lane 2). According to the crystal structure of
Figure 5. eIF4A3-binding deficient mutants of BTZ do not interact with the EJC, but elicit NMD when tethered to the RNA. (A)
Positions of the BTZ mutations in the EJC as shown in Figure 2. (B) Immunoprecipitations were done from RNAse A-treated lysates of HeLa cells,
which were transfected with FLAG-BTZ and FLAG-BTZ mutants or unfused FLAG as negative control together with V5-tagged UPF3b, eIF4A3, Y14, and
MAGOH. Co-precipitated proteins were detected by immunoblotting using an anti V5 antibody. (C) Splicing reactions using MINX as substrate RNA
were supplemented with extracts expressing the indicated FLAG-tagged BTZ mutants or unfused FLAG-tag as negative control. Reactions were
immunoprecipitated with FLAG affinity gel. Twelve percent of the total input material was loaded in the input panel. (D) Northern blot analysis of
total cytoplasmic RNA from HeLa cells that were transfected with expression plasmids for lNV5-tagged BTZ or mutants of BTZ together with the
4boxB reporter plasmid and the transfection control plasmid. Percentages (%) represent the mean of three independent experiments6standard
deviations (SD). Bottom panel: expression levels of the tethered BTZ mutants were detected by immunoblot analysis with a V5 antibody. GFP served
as an internal loading control.
doi:10.1371/journal.pbio.1000120.g005
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eIF4A3 [19,20]. When tested experimentally, mutants of BTZ that
show decreased eIF4A3 binding also co-immunoprecipitate
reduced amounts of spliced MINX mRNA (Figure 5C). In
excellent correlation with the protein co-immunoprecipitation
data, the BTZ mutant 218 displays the weakest RNA association
(Figure 5C, lane 13) which confirms that BTZ binds to the RNA
mainly through its interaction with eIF4A3 [19,20]. Compared to
BTZ 218, the mutant 220/221 shows increased RNA association
despite having only slightly stronger eIF4A3 binding. This suggests
that residues of BTZ could also directly contribute to its
interaction with RNA.
BTZ Bridges the EJC to UPF1-Dependent RNA
Degradation (NMD)
We next addressed the question of whether BTZ mutants that
are not able to bind efficiently to the RNA through the EJC core
proteins are able to activate NMD if bound to the RNA
independently of the EJC. We thus performed BTZ tethering
experiments. Remarkably, all of the BTZ mutants tested above
show full activity in the NMD tethering assay (Figure 5D). These
data indicate that the NMD-activating domain of BTZ is
separable from the EJC-interacting domain. The residues of
BTZ that stabilize the interaction with eIF4A3 and the other EJC
proteins are not required for its NMD function when BTZ is
independently tethered to the RNA. In contrast, recruitment of
BTZ to a spliced mRNA requires its interaction with the EJC.
These data identify BTZ as a functional bridging factor between
the EJC and its NMD function.
To identify the NMD effector domain of BTZ, we generated N-
and C-terminal deletion mutants with or without the 218 mutation
that reduces eIF4A3 binding (Figure 6A). Functional analysis in
the NMD tethering assay shows that C-terminal deletions of up to
223 amino acids maintains the NMD activity of BTZ even in the
presence of the 218 mutation (Figure 6B, lanes 4–9). Similarly, N-
terminal deletions of 40 or 70 amino acids display only small
effects (lanes 10–13). In contrast, deletion of 110 or 136 N-
terminal amino acids reduces the activity of the respective mutant
by approximately 2-fold. This loss of function is severely
aggravated by the 218 mutation.
To test whether the activity of BTZ 218 is UPF1-dependent, a
central hallmark of NMD, we depleted UPF1 in the tethering
assay. UPF1 depletion abrogates the activity of the BTZ 218
mutant (Figure 6C), while the restoration of normal UPF1 levels
by transfection of an expression vector for siRNA-insensitive UPF1
[14] completely restores NMD. This result proves that the
observed UPF1 dependence is not caused by nonspecific or off-
target effects. Taken together, these findings reveal that BTZ
(likely amino acids (aas) 41–480) carries an EJC-independent
Figure 6. BTZ links the EJC with UPF1-dependent NMD. (A) Schematic representation of the BTZ deletion mutants used in (B). The SELOR
domain is displayed as a gray box, the size of the respective N- or C-terminal deletion is indicated. (B) Northern blot analysis of total cytoplasmic RNA
from HeLa cells that were transfected with expression plasmids for lNV5-tagged BTZ or deletion mutants of BTZ together with the 4boxB reporter
plasmid and the transfection control plasmid. The presence of the 218 mutation in each mutant is indicated. Percentages (%) represent the mean of
four independent experiments6standard deviations (SD). Bottom panel: expression levels of the tethered BTZ mutants were detected by
immunoblot analysis with an anti-V5 antibody. GFP served as internal loading control. (C) Northern blot analysis of total cytoplasmic RNA from HeLa
cells that were transfected with siRNAs targeting Luciferase (negative control) or UPF1. Thirty hours later, the cells were transfected with the
expression plasmid for lNV5-tagged BTZ 218 together with the 4boxB reporter plasmid and the transfection control plasmid. The siRNA depletion
was rescued by transfecting a siRNA-insensitive expression plasmid for UPF1. Percentages (%) represent the mean of four independent
experiments6standard deviations (SD). (D) Upper panel: immunoblot analysis of UPF1 expression in lysates from cells used in (C) with a UPF1-specific
antibody. Tubulin served as control for comparable loading. Lower panel: the expression of tethered BTZ 218 was detected by immunoblot analysis
with an anti-V5 antibody. GFP served as internal loading control.
doi:10.1371/journal.pbio.1000120.g006
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EJC to the NMD machinery.
BTZ Is Required for NMD
Our data indicate that BTZ can activate UPF1-dependent
NMD of a reporter mRNA in a tethering assay and predict that
BTZ depletion should specifically inhibit NMD efficiency in a
physiological model. Hence, we tested the role of BTZ in bona fide
NMD by depleting endogenous BTZ protein in cells transfected
with wild-type and nonsense-mutated TCR-b constructs as NMD
reporters. We measured the efficiency of NMD in cells that were
independently transfected with one out of three different siRNAs
targeting BTZ (Figure S4). Depletion of BTZ by any of these three
siRNAs (Figure 7A) significantly up-regulates the nonsense-
mutated TCRb reporter mRNA by approximately 3-fold
(Figure 7B). The restoration of BTZ levels by a siRNA(2)-
insensitive BTZ variant (Figure 7C) efficiently restored normal
NMD activity (Figure 7D), confirming the specificity of the BTZ
effect and excluding off-target effects.
If BTZ links the EJC to UPF1-dependent NMD, we reasoned
that these two proteins should exit in one complex and that this
complex should occur independently of the proteins UPF2 or
UPF3. To test this hypothesis, we performed immunoprecipita-
tions with FLAG-tagged UPF1 or mutants of UPF1 that lack
interaction with UPF2 [43]. Whereas wild-type UPF1 co-
immunoprecipitates UPF2, UPF3b, and BTZ (Figure 7E, lane
2), the two mutants precipitate only BTZ but no detectable
quantities of either UPF2 or UPF3b (Figure 7E, lanes 3 and 4).
Similarly, complex formation of BTZ and UPF1 was not
compromised in cells depleted of UPF2 (Figure 7F). Hence, the
interaction between BTZ and UPF1 is not mediated by UPF2 or
UPF3b. These data demonstrate that BTZ can associate with the
NMD protein UPF1 in a complex that is distinct from the complex
containing UPF2 and UPF3b.
Discussion
The core EJC consisting of the recombinant proteins eIF4A3,
BTZ, MAGOH, and Y14 self-assembles in the presence of ATP
on a RNA substrate in vitro [18], but this core EJC does not
convey positional information that results from spliceosomal EJC
assembly. The data provided by the crystal structure of the
recombinant EJC core [19,20] have provided a basis for our
experimental strategy to analyze the assembly of the EJC by the
spliceosome with an array of EJC protein mutants.
Definition and Assembly of a Minimal Trimeric Pre-EJC
We report here the definition of an ordered and hierarchical
assembly pathway of the EJC during splicing (Figure 8A). This
ordered assembly is initiated by the binding of eIF4A3 and
Figure 7. BTZ is required for efficient NMD and interacts with UPF1. (A) Immunoblot analysis for BTZ of protein lysates from HeLa cells
transfected with Luciferase siRNA (negative control; lanes 1–4) or BTZ siRNAs (lanes 5–7). Dilutions corresponding to 50%, 20%, or 10% (lanes 2–4) of
the initial protein amount (lane 1) of negative control, siRNA-transfected cells were loaded to assess the efficiency of the BTZ depletion. Reprobing
with a tubulin-specific antibody was performed to control for loading. (B) Northern blot analysis of RNA from HeLa cells transfected with the indicated
siRNAs and subsequently with the NMD reporter plasmids TCR-b wt or NS98 and a plasmid controlling for transfection efficiency. The numbers
indicate changes in mRNA abundance6SD determined by analysis of four independent experiments. (C) Immunoblot analysis of protein lysates from
HeLa cells transfected with siRNA targeting Luciferase (lane 1) or siRNA (2) targeting BTZ (lanes 2–3) as described in (A). To rescue the siRNA
depletion, a siRNA-insensitive mutant of BTZ was co-transfected (lane 3). (D) Northern blot analysis of RNA from HeLa cells that were transfected with
siRNA (lane 2). The NMD reporter plasmids TCR-b wt or NS98 and a transfection efficiency control were transfected together with a plasmid
expressing a siRNA-insensitive variant of BTZ (lanes 5 and 6). The numbers indicate changes in mRNA abundance6SD determined by the analysis of
four independent experiments. (E) Immunoprecipitations were done from RNAse A-treated lysates of HeLa cells that were transfected with FLAG-
UPF1 and FLAG-UPF1 mutants together with V5-tagged BTZ. Co-precipitated proteins were detected by immunoblotting using UPF2, UPF3b, or anti
V5 antibodies. (F) Immunoprecipitations were done from RNAse A-treated lysates of HeLa cells that were treated with siRNA and transfected with
FLAG-BTZ. Co-precipitated proteins were detected by immunoblotting using an anti UPF1 antibodies. The depletion of UPF2 was assessed in the cell
lysates with an UPF2 antibody. The membrane was reprobed with a tubulin antibody to control for loading.
doi:10.1371/journal.pbio.1000120.g007
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(step 1). A candidate binding partner of eIF4A3 within the
spliceosome may be the protein IBP160 (AQR) that has been
suggested to recruit the EJC to the intron during splicing [44].
Considering the data shown in Figure 4 and the crystal structure of
the EJC core [19,20], we propose that the spliceosome introduces
eIF4A3 to the RNAwith an associated change of the conformation of
this protein after ATP binding (step 2). This enables the binding of
MAGOH-Y14 (step 3), completing the assembly of the first stable
EJCintermediatethatwerefertoasminimalpre-EJCortrimericpre-
EJC. This assembly pathway also takes full account of both, a
previous analysis of EJC assembly [24] and the analysis of purified
spliceosomes and spliceosomal sub-complexes, where eIF4A3,
MAGOH, and Y14 were identified in the splicing complex B, the
activated spliceosome (B*), and splicing complex C [26–28].
Our data also suggest that the trimeric pre-EJC represents the
platform that physiologically interacts with additional EJC
components. The purification of spliced mRNPs devoid of
detectable amounts of BTZ has been reported, suggesting that
stable (pre-) EJCs without BTZ can occur under physiological
conditions [45]. Interestingly, recombinant EJC proteins from
bacteria fail to interact with the spliceosome, and these bacterially
expressed proteins appear to assemble on the RNA during the
second step of splicing [38]. The differences of the results obtained
with bacterially expressed proteins [38] and EJC proteins from
eukaryotic sources (this study and [26]) suggest that posttransla-
tional modifications of EJC proteins in mammalian cells may be
required for the association of EJC protein(s) with the spliceosome.
The spliceosome undergoes conformational and structural
changes during its assembly and activation for splicing [26,27].
How the suggested conformational change of eIF4A3 is achieved
in this context remains an open question. The conformational
change of eIF4A3 may be a consequence of the rearrangements
that occur within the spliceosome when splicing proceeds. Because
eIF4A3 is found in the activated spliceosome, eIF4A3 may adopt
the closed, RNA-bound conformation during the transition from
the activated spliceosome to splicing complex C. The results
shown in Figures 2–4 strongly suggest that a significant fraction of
eIF4A3 adopts the MAGOH-Y14–bound state before exon
ligation. We thus propose that eIF4A3 assumes a closed
confirmation and is stably locked onto the RNA in the C-complex
upon binding of ATP and MAGOH-Y14.
From the Trimeric Pre-EJC to the NMD-Competent Core
EJC
BTZ and the NMD factor UPF3b bind to the trimeric pre-EJC
after the mRNA is released from the spliceosome. Considering the
predominant localization of BTZ in the cytoplasm [41,42] and the
fact that BTZ can join the trimeric pre-EJC after splicing
(Figure 1F), this interaction may likely occur after nuclear export
of the mRNP. BTZ is thus proposed to join the EJC at a later
(possibly cytosolic) step of assembly. Interestingly, the interaction
between the trimeric pre-EJC and BTZ depends on exposed
surface residues of eIF4A3 including aa 178/179 that also stabilize
the association of eIF4A3 with spliceosomal complexes before the
second step of splicing (Figure 3D and 3E). This overlap indicates
that BTZ and the spliceosome interact with the same region of
eIF4A3, a finding that can explain why nuclear BTZ fails to enter
spliceosomal complexes and why BTZ has not been found in
purified spliceosomal complexes [26].
Figure 8. Ordered assembly of the EJC by the spliceosome. (A) Assembly pathway of the EJC. For details, see Discussion. (B) The exon junction
complex recruits NMD activating proteins and combines different complexes leading to UPF1-dependent NMD. The model of the BTZ-dependent
pathway is derived from the data presented in this work, whereas the model of the UPF3b-UPF2-UPF1-dependent pathway is derived from collective
data of earlier publications [34,35,39,49]. Details are explained in the Discussion.
doi:10.1371/journal.pbio.1000120.g008
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NMD Pathways
Alternative pathways of NMD have previously been proposed to
exist in mammals [14,36,43]. The corresponding EJC architec-
tures and mechanistic aspects of the proposed alternative NMD
pathways are not known so far.
The recruitment of BTZ to the minimal trimeric pre-EJC offers
a biochemical basis for a UPF3b- and UPF2-independent NMD
pathway, because BTZ can interact with UPF1 independently of
UPF2 and UPF3b (Figure 7). Note that the degradation of some
endogeneous NMD targets depends selectively on either BTZ or
UPF2 [14]. Furthermore, the interaction between UPF2 and
UPF1 is not strictly required for NMD [43], and UPF3b-
independent NMD has been documented in cell lines and
confirmed in humans with UPF3b null-mutations [36,37]. We
thus propose the existence of a BTZ-dependent NMD pathway
that shares the requirement for UPF1 with the classical UPF3b-
UPF2 pathway (Figure 8B).
The NMD-promoting properties of BTZ (Figures 5 and 6) are
important for the understanding of the functions of the other EJC
proteins eIF4A3 and MAGOH-Y14. EJC-independent BTZ
recruitment (by tethering) is sufficient to induce reporter mRNA
degradation, and MAGOH-Y14 are not required under these
conditions. BTZ also displays some pre-mRNA binding capacity
(Figure 1) [38], which may function to destabilize a subset of
unspliced mRNAs. However, under physiological conditions,
recruitment of BTZ to an RNA is strictly EJC-dependent, which
secures the specificity of the NMD pathway for spliced and
translated mRNAs that retain an EJC. This EJC specificity is also
maintained in the ‘‘classical’’ NMD pathway that depends on the
interaction between the EJC and UPF3b, and subsequently UPF2
and UPF1 [35,46–49].
Physiologically, the role of alternative NMD pathways has not
yet been defined. It is possible that these pathways are
complementary or partly redundant to ensure maximal efficiency
of quality control to safely eliminate otherwise detrimental faulty
transcripts [50,51]. Alternatively, distinct NMD pathways may act,
e.g., in different tissues, at different times of development, or at
different times of the cell cycle, enabling discriminating control
over the expression of NMD targets, especially physiological
endogenous transcripts.
Materials and Methods
Plasmids
Plasmid constructs b-globin wild-type, -NS 39, -4boxB, -6MS2,
pCI-lNV5, pCI-MS2, pCI-FLAG, pCI-V5, the transfection
control (wt300+e3), and expression vectors for Y14, MAGOH,
eIF4A3, BTZ, and UPF3b were described previously [14,15]. Full-
length PYM (WIBG) and CBP80 cDNAs were obtained by reverse
transcription (RT)-PCR using total HeLa cell RNA and inserted
into pCI-neo FLAG. Mutants of MAGOH were generated by site-
directed mutagenesis or described previously [14]; mutants of
eIF4A3 and BTZ were generated by site-directed mutagenesis.
MINX [52] was cloned EcoRI/BamHI into pGEM4. MINX GG,
MINX (15), MINX GG (15), and MINX Di were generated by
PCR-mutagenesis and inserted into pGEM4. All constructs were
verified by DNA sequencing.
Cell Culture, Plasmid Transfections, and siRNA
Transfections
HeLa cells were grown and transfected with plasmid DNA or
siRNA as previously described [14]. For tethering experiments,
0.8 mg of MS2- or lNV5-fusion construct, 0.5 mg of the control
plasmid (wt300+e3), 2 mg of the 4boxB or 6MS2 reporter vector,
and 0.2 mg of a GFP expression plasmid were transfected. For
transfections of b-globin wild-type or NS39, we used 1 mg of pCI-
wt or NS39, 0.5 mg of the control plasmid, and 0.3 mg of the GFP
expression vector. Transfections for immunoprecipitations were
done with 3–4 mg of the FLAG-expression plasmid and 1 mgo f
GFP- and 0.8 mg V5-expression plasmids. GripTite 293 MSR cells
(Invitrogen) were transfected with 6–8 mg of FLAG expression
plasmids and 2 mg GFP expression vector in 10-cm cell culture
dishes. siRNA transfections were done as previously described
[14]. DNA target sequences for BTZ siRNAs were: (1)
AACAUUCGCUCAGCUCAUAAU [16]; (2) GGUGGAUU-
CUAGUACAAGUTT (Ambion siRNA s22391); and (3) CCAC-
CUCAGUUUAACCGGATT (Ambion siRNA s22392).
Complementation of the UPF1 depletion was done with the
siRNA insensitive FLAG-UPF1
R expression plasmid described
before [14]. The complementation of the BTZ depletion was done
analogously to the UPF1 complementation by transfecting 0.3 mg
of an expression plasmid for a siRNA-insensitive FLAG-BTZ
R.
RNA Extraction and Analysis
Total cytoplasmic RNA or total RNA were analyzed by
Northern blotting [14]. Signals were quantified in a FLA-3000
fluorescent image analyzer (Raytest). Percentages were calculated
as described [14,15].
Protein Extraction, Immunoblot Analysis, and
Immunoprecipitation
Immunoblot analysis was performed using 10–30 mgo f
cytoplasmic or whole-cell extracts. After SDS-PAGE, proteins
were transferred to a PVDF-membrane. Blocking was done with
5% non-fat skimmed milk in TBS-Tween (0.1%).
FLAG complexes were immunoprecipitated from RNase A-
treated HeLa cell lysates (20 mg/ml) with M2 anti-FLAG agarose
(Sigma) at 4uC for 1–2 h in lysis buffer (50 mM Tris [pH 7.2],
150 mM NaCl, 1 mM EDTA, 0.5 mM PMSF, 0.5% Triton X-
100, + complete [Roche] protease inhibitor). Beads were washed
four times in lysis buffer without protease inhibitors. Precipitated
complexes were eluted with SDS-sample buffer and analyzed by
immunoblotting.
In Vitro Transcription, In Vitro Splicing, and RNP
Immunoprecipitation
Capped transcripts were generated by in vitro transcription with
SP6 RNA polymerase in the presence of m7GpppG cap analog
(Promega). In vitro splicing reactions were performed for 2 h in
HeLa cell nuclear extract (CIL Biotech) that was supplemented
with 293 whole-cell extracts from cells transfected with different
FLAG-tagged EJC proteins [53]. To prepare HEK293 whole-cell
extracts, cells from a single 10-cm dish were resuspended in 200–
300 ml of Buffer E (20 mM Hepes-KCl, pH 7.9, 100 mM KCl,
0.2 mM EDTA, 10% glycerol, 1 mM DTT) and lysed by
sonication [53]. FLAG-immunoprecipitations of RNPs were
performed with FLAG-M2 affinity gel in mRNP IP buffer
(20 mM HEPES KOH, pH 7.9, 200 mM NaCl, 2 mM MgCl2,
0.2% Triton X-100, 0.1% NP-40, 0.05% Na-Deoxycholate).
Empigen BB was used at a concentration of 1% during the binding
and washing steps (Figure 4C). RNAs were recovered by TRI
reagent extraction and isopropanol precipitation, a proteinase K
treatment was included in the experiment shown in Figure 4C.
The RNA was analyzed by denaturing PAGE. Twelve to fifteen
percent of the total input material was loaded in the input panels
(8% in Figure 1E).
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Antibodies to BTZ [42] and UPF2 [34] were kindly provided by
Catherine Tomasetto and Jens Lykke-Andersen, respectively.
Antibodies to UPF1 were raised using a GST-tagged N-terminal
fragment (400 aa) of UPF1, antibodies to MS2 were raised using
recombinant GST-tagged full length MS2, antibodies to UPF3b
were raised using a recombinant GST-tagged C-terminal fragment
of UPF3b. The antibody to GFP was from Abcam, the FLAG- and
V5-antibodies were from Sigma.
Supporting Information
Figure S1 Splicing-independent BTZ binding to mini-
mal EJC cores consisting of eIF4A3 and MAGOH-Y14, (A)
Splicing reactions using MINX as substrate RNA were supple-
mented with recombinant, Strep-tagged EJC proteins as indicated.
Pulldowns were performed with StrepTactin spin columns.
Positions of the unspliced transcript and the spliced product are
displayed schematically. (B) Nuclear extracts were supplemented
with the indicated recombinant proteins and an intronless MINX
transcript (MINX i). Pulldowns were performed as in (A). (C)
Comassie Brilliant Blue stained gel of the recombinant proteins
used in (A) and (B).
Found at: doi:10.1371/journal.pbio.1000120.g001 (0.87 MB TIF)
Figure S2 Crosslinking does not stabilize interactions
between the pre-EJC and the short 59 splicing substrate.
Splicing reactions using MINX, MINX GG, or MINX GG (15) as
substrate RNAs were supplemented with FLAG-eIF4A3, FLAG-
Y14, or FLAG-expressing extracts as described in Figure 4.
Reactions were UV-crosslinked and immunoprecipitations were
done with FLAG affinity gel in the presence of 1% Empigen BB.
Crosslinked proteins were digested with Proteinase K after
immunoprecipitation. Twelve percent of the total input material
was loaded in the input lanes.
Found at: doi:10.1371/journal.pbio.1000120.g002 (3.23 MB TIF)
Figure S3 Comparison of immunoprecipitation condi-
tions with or without crosslinking. Splicing reactions using
MINX GG as substrate RNAs were supplemented with FLAG-
eIF4A3, FLAG-Y14, or FLAG-expressing extracts. Reactions
were divided into two parts: one was not treated (lanes 7–9) the
other was UV-crosslinked (lanes 4–6). Immunoprecipitations were
done with FLAG affinity gel in the presence of 1% Empigen BB.
Proteins were digested with Proteinase K after immunoprecipita-
tion and RNA extracted with TRI reagent. Ten percent of the
total input material was loaded in the input lanes.
Found at: doi:10.1371/journal.pbio.1000120.g003 (1.58 MB TIF)
Figure S4 Establishing the knockdown of BTZ. Quanti-
tative real-time PCR (qRT-PCR) measurement of BTZ mRNA
levels after transfection of siRNA targeting Luciferase (Luc) or
BTZ (1; 2; 3).
Found at: doi:10.1371/journal.pbio.1000120.g004 (0.08 MB TIF)
Table S1 MAGOH mutants used in this study. The table
summarizes the names and respective mutations of the MAGOH
mutants used in this study. Previously published mutations are
indicated.
Found at: doi:10.1371/journal.pbio.1000120.g005 (0.03 MB
DOC)
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